Amit Verma, MD

home / authors / amit-verma-md

Articles

QoL of Cenobamate in Treatment-Resistant Epilepsy

QoL of Cenobamate in Treatment-Resistant Epilepsy

Trevor J. Resnick, MD;Amit Verma, MD
February 17th 2021
Using Midazolam Nasal Spray for Seizure Clusters

Using Midazolam Nasal Spray for Seizure Clusters

Trevor J. Resnick, MD;Amit Verma, MD
February 15th 2021
Interim Analysis of Diazepam Nasal Spray in Epilepsy

Interim Analysis of Diazepam Nasal Spray in Epilepsy

Trevor J. Resnick, MD;Amit Verma, MD
February 9th 2021
BELIEVE Trial: Developmental and Epileptic Encephalopathies

BELIEVE Trial: Developmental and Epileptic Encephalopathies

Trevor J. Resnick, MD;Amit Verma, MD
February 8th 2021
FAME Study: Partial-Onset Seizures

FAME Study: Partial-Onset Seizures

Trevor J. Resnick, MD;Amit Verma, MD
February 4th 2021
Focal Seizures: Post-hoc Analysis of Cenobamate

Focal Seizures: Post-hoc Analysis of Cenobamate

Trevor J. Resnick, MD;Amit Verma, MD
January 20th 2021
ELEKTRA Study in Dravet and Lennox-Gastaut Syndromes

ELEKTRA Study in Dravet and Lennox-Gastaut Syndromes

Trevor J. Resnick, MD;Amit Verma, MD
January 19th 2021
Safety and Efficacy of CBD in Patients With TSC

Safety and Efficacy of CBD in Patients With TSC

Trevor J. Resnick, MD;Amit Verma, MD
January 17th 2021
Clinical Benefit of Fenfluramine in Dravet Syndrome

Clinical Benefit of Fenfluramine in Dravet Syndrome

Trevor J. Resnick, MD;Amit Verma, MD
January 14th 2021
Phase 4 ELEVATE Study

Phase 4 ELEVATE Study

Trevor J. Resnick, MD;Amit Verma, MD
January 13th 2021
Treating Patients Who Are Unresponsive to Therapy

Treating Patients Who Are Unresponsive to Therapy

Amit Verma, MD
November 10th 2020
Addressing Nonadherence to Therapy

Addressing Nonadherence to Therapy

Amit Verma, MD
November 10th 2020
How Epilepsy Treatment Efficacy Is Determined

How Epilepsy Treatment Efficacy Is Determined

Amit Verma, MD
November 10th 2020
Anticonvulsants to Treat Epilepsy and Alternatives

Anticonvulsants to Treat Epilepsy and Alternatives

Amit Verma, MD
November 10th 2020
The Classification of Epilepsy and Seizures

The Classification of Epilepsy and Seizures

Amit Verma, MD
November 10th 2020
Epilepsy Case Presentation and Diagnostic Process

Epilepsy Case Presentation and Diagnostic Process

Amit Verma, MD
November 10th 2020
Real-World Practice: Perampanel for Partial-Onset Seizures

Real-World Practice: Perampanel for Partial-Onset Seizures

Amit Verma, MD
November 10th 2020
A Treatment Option for Uncontrolled Partial-Onset Seizures

A Treatment Option for Uncontrolled Partial-Onset Seizures

Amit Verma, MD
November 10th 2020
How Treatment Efficacy Is Determined

How Treatment Efficacy Is Determined

Amit Verma, MD
November 10th 2020
Antiepileptic Therapy Adverse Effects and Nonadherence

Antiepileptic Therapy Adverse Effects and Nonadherence

Amit Verma, MD
November 10th 2020
Antiepileptic Therapy Half-Life, Dosing & Black Box Warning

Antiepileptic Therapy Half-Life, Dosing & Black Box Warning

Amit Verma, MD
November 10th 2020
Seizure Classification and Goals of Therapy

Seizure Classification and Goals of Therapy

Amit Verma, MD
November 10th 2020
Epilepsy Prevalence and Therapy Resistance

Epilepsy Prevalence and Therapy Resistance

Amit Verma, MD
November 10th 2020
A 55-Year-Old Woman With Epilepsy

A 55-Year-Old Woman With Epilepsy

Amit Verma, MD
November 10th 2020

Latest Updated Articles

Kelsey E. Poisson, MD (Credit: Nationwide Children’s)
Published: November 27th 2024 | Updated: December 11th 2024
Race, Socioeconomic Status Play Major Role in Disparities Seen in Pediatric NMOSD Outcomes
Robert A. Hauser, MD, MBA (Credit: USF Health)
Published: October 17th 2024 | Updated: October 21st 2024
FDA Approves AbbVie’s 24-Hour Foscarbidopa/Foslevodopa Pump for Advanced Parkinson Disease Treatment
Jacob McCauley, PhD (Credit: Miami Miller School of Medicine)
Published: September 18th 2024 | Updated: September 20th 2024
Multi-Ethnic Study Identifies Ancestry-Specific Genetic Variants that Influence Risk of Multiple Sclerosis
Todd Sherer, PhD (Credit: The Michael J. Fox Foundation for Parkinson's Research)
Published: September 9th 2024 | Updated: September 11th 2024
FDA Supports Alpha-Synuclein Seed Amplification Assay Biomarker for Clinical Trials in Parkinson Disease
Lee Golden, MD (Credit: PTC Therapeutics)
Published: August 24th 2024 | Updated: August 26th 2024
Vatiquinone Pharmacokinetics Influenced by CYP3A4 Inhibitors and Inducers in Phase 1 Study
Renaud Du Pasquier, MD (Credit: University of Lausanne)
Published: August 22nd 2024 | Updated: August 23rd 2024
Novel Cell-Based Assay Enhances Detection of Autoantibodies in Neurological Disorders
© 2025 MJH Life Sciences

All rights reserved.